Literature DB >> 1855058

Use of thalidomide in leprosy.

C L Crawford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855058      PMCID: PMC1670367          DOI: 10.1136/bmj.302.6792.1603-d

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Leprosy in reaction: a medical emergency.

Authors:  A S Malin; M F Waters; S A Shehade; M M Roberts
Journal:  BMJ       Date:  1991-06-01

2.  Treatment of erythema nodosum leprosum with thalidomide.

Authors:  C L Crawford
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

3.  Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study.

Authors:  P M Fullerton; D J O'Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-12       Impact factor: 10.154

4.  Development of polyneuropathy during thalidomide therapy.

Authors:  C H Wulff; H Høyer; G Asboe-Hansen; H Brodthagen
Journal:  Br J Dermatol       Date:  1985-04       Impact factor: 9.302

5.  Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus.

Authors:  J Knop; G Bonsmann; R Happle; A Ludolph; D R Matz; E J Mifsud; E Macher
Journal:  Br J Dermatol       Date:  1983-04       Impact factor: 9.302

  5 in total
  5 in total

1.  Use of thalidomide in leprosy.

Authors:  M F Waters
Journal:  BMJ       Date:  1991-08-24

2.  Use of thalidomide in leprosy.

Authors:  M Hooper
Journal:  BMJ       Date:  1991-11-30

3.  Guideline for the clinical use and dispensing of thalidomide.

Authors:  R J Powell; J M Gardner-Medwin
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

4.  Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.

Authors:  T C Peterson
Journal:  Can J Infect Dis       Date:  1995-01

Review 5.  Thalidomide: rationale for renewed use in immunological disorders.

Authors:  U Schuler; G Ehninger
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.